Is the US prepared to deal with another pandemic or widespread health crisis?

Let me gather more details from key recent reports and assessments.No, the United States is not fully prepared for another pandemic or major widespread health crisis, though it has made notable improvements in some areas since COVID-19 and retains significant capabilities. Persistent gaps in coordination, funding sustainability, workforce, public trust, state-level readiness, and recent policy shifts leave substantial vulnerabilities.[1]

Assessments from the Government Accountability Office (GAO), bipartisan commissions, public health organizations like Trust for America’s Health (TFAH), CDC testimony, and expert analyses consistently highlight that while technical and stockpile enhancements help, systemic issues and political cycles undermine resilience. Biological threats (natural, accidental, or deliberate) are growing due to factors like climate change, globalization, zoonotic spillover (e.g., H5N1 bird flu), antimicrobial resistance, and advancing biotechnology.[2]

Post-COVID Improvements

The COVID-19 response (over 1 million U.S. deaths) exposed weaknesses but drove progress under the Biden administration and prior investments:

GAO and others note that implementing remaining recommendations would further help. Biden-era roadmaps emphasized sustained vigilance.[1]

Persistent and Recurring Gaps

The 2024 Bipartisan Commission on Biodefense National Blueprint (updating earlier work) concluded that “immediate action” is needed across leadership, intelligence, science/tech, preparedness, detection/surveillance, and response. It issued 36 recommendations (e.g., stronger White House biodefense leadership via National Security Advisor role, quadrennial reviews, replace BioWatch), noting the threat is real and growing, with the U.S. still vulnerable despite partial progress on prior ideas.[2][11]

Recent Developments and Concerns (Post-2025)

Expert analyses, polls, and reports indicate that policy changes under the second Trump administration have weakened aspects of preparedness:

ASPR remains operational for responses (e.g., Ebola, weather events, H5N1 PPE distribution), and some domestic stockpiles/surveillance endure. However, many experts argue these shifts reverse gains, reduce innovation leadership, impair early international detection/containment, and heighten risks—potentially taking years to rebuild.[18][19]

H5N1 monitoring (animal spread, limited human cases) included vaccine stockpiling and mRNA development investments, but concerns about testing, farm worker protections, and escalation persist.[20]

Bottom Line and Path Forward

The U.S. has stronger stockpiles, some modernized surveillance, and proven rapid countermeasure platforms than in 2019. It can handle many localized or moderate threats better. However, it is not adequately prepared for a severe, fast-spreading novel pandemic comparable to (or worse than) COVID-19, especially one involving high transmissibility, severity, or simultaneous crises. Vulnerabilities in leadership continuity, sustained funding, workforce, equity, trust, and global ties mean response could again be delayed, uneven, and costly in lives and economy (COVID’s U.S. economic toll estimated in the trillions).[21]

Preparedness is not binary—it requires continuous investment, bipartisan commitment beyond election cycles, addressing social determinants of health, domestic manufacturing, and international cooperation. Recommendations commonly include fully implementing GAO/Commission findings, stable public health funding (beyond emergency supplements), PAHPA reauthorization/strengthening, workforce support, data modernization, MCM acceleration, and rebuilding trust through clear communication. Without these, the pattern of “forget and underfund until the next crisis” risks repeating.[22]

Ongoing threats (measles resurgence, Ebola, H5N1, antimicrobial resistance, potential engineered pathogens) underscore the urgency. Capabilities exist to improve significantly if prioritized as a national security issue equivalent to other defense priorities.